AP Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	1,442	278.61	1,048
Short-Term Investments	100	461.41	30.71
Cash & Short-Term Investments	1,542	740.02	1,079
Cash Growth	108.33%	-31.40%	-
Other Receivables	36.18	24.6	14.48
Receivables	36.18	24.6	14.48
Prepaid Expenses	3.63	1.03	0.85
Total Current Assets	1,581	765.64	1,094
Property, Plant & Equipment	109.33	116.41	3.02
Other Intangible Assets	3.55	4.23	5.34
Other Long-Term Assets	32.8	4.48	0.78
Total Assets	1,727	890.76	1,103
Accrued Expenses	22.64	16.72	2.48
Current Portion of Leases	11.65	11.65	-
Other Current Liabilities	5.37	2.51	2.04
Total Current Liabilities	39.67	30.88	4.52
Long-Term Leases	59.26	70.43	-
Other Long-Term Liabilities	5.46	5.35	-
Total Liabilities	104.38	106.65	4.52
Common Stock	849.87	647.48	647.48
Additional Paid-In Capital	1,197	475.92	739.72
Retained Earnings	-422.75	-339.3	-288.54
Comprehensive Income & Other	-1.08	-	-
Shareholders' Equity	1,623	784.11	1,099
Total Liabilities & Equity	1,727	890.76	1,103
Total Debt	70.91	82.08	-
Net Cash (Debt)	1,471	657.94	1,079
Net Cash Growth	123.54%	-39.01%	-
Net Cash Per Share	19.53	10.16	20.49
Filing Date Shares Outstanding	84.99	64.75	56.55
Total Common Shares Outstanding	84.99	64.75	56.55
Working Capital	1,542	734.77	1,090
Book Value Per Share	19.09	12.11	19.43
Tangible Book Value	1,619	779.88	1,093
Tangible Book Value Per Share	19.05	12.04	19.33
Machinery	39.3	36.93	31.34
Construction In Progress	-	28.2	-
Leasehold Improvements	35.5	-	1

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.